Keywords:
Interventional non-vascular, Respiratory system, CT, Biopsy, Cancer, Outcomes
Authors:
J. Lim, L. K. Ng
DOI:
10.26044/ranzcr2022/R-0112
References
1. Lung cancer: Health Quality & Safety Commission [Internet]. Hqsc.govt.nz. 2022 [cited 12 March 2022]. Available from: https://www.hqsc.govt.nz/our-data/atlas-of-healthcare-variation/lung-cancer/
2. Winokur R, Sullivan B, Madoff D, Pua B. Percutaneous Lung Biopsy: Technique, Efficacy, and Complications. Seminars in Interventional Radiology. 2013;30(02):121-127.
3. de Margerie-Mellon C, de Bazelaire C, de Kerviler E. Image-guided biopsy in primary lung cancer: Why, when and how. Diagnostic and Interventional Imaging. 2016;97(10):965-972.
4. Lee, W. K., Lau, E. W., Chin, K., Sedlaczek, O., & Steinke, K. Modern diagnostic and therapeutic interventional radiology in lung cancer. Journal of thoracic disease. 2013;5(5):511–523.
5. Heerink W, de Bock G, de Jonge G, Groen H, Vliegenthart R, Oudkerk M. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. European Radiology. 2016;27(1):138-148